REVIA Side Effects

6231583-7 | Diplopia, Impaired Driving Ability, Impaired Work Ability
on Jun 12, 2009 Male patient from UNITED STATES , 42 years of age, weighting 196.0 lb, was treated with Revia (View Usage). Patient experienced the following unwanted or unexpected effects: diplopia, impaired driving ability, impaired work ability. Revia dosage: .

6027966-0 | Blood Alcohol Increased, Coma
Patient was taking Revia (View Usage). Patient had the following side effects: blood alcohol increased, coma on Dec 10, 2008 from FRANCE Additional patient health information: Female patient , 51 years of age, . Revia dosage: 28 Dosage Form Total. During the same period patient was treated with LAROXYL (AMITRIPTYLINE HCL) (800 Milligram Total) (View Laroxyl (amitriptyline Hcl) Review and Laroxyl (amitriptyline Hcl) Label ), OXAZEPAM (20 Dosage Form Total) (View Oxazepam Review and Oxazepam Label ), BENAZEPRIL HCL AND HYDROCHLOROTHIAZIDE (30 Dosage Form Total) (View Benazepril Hcl And Hydrochlorothiazide Review and Benazepril Hcl And Hydrochlorothiazide Label ), ALCOHOL (View Alcohol Review and Alcohol Label ). Patient was hospitalized.

5975007-3 | Dizziness, Feeling Of Body Temperature Change, Myalgia, Vomiting
Adverse event was reported on Nov 19, 2008 by a Male patient taking Revia (View Usage) (Dosage: 50 Milligram 1 Day) was diagnosed with alcoholism (What is alcoholism?) and. Location: AUSTRALIA , 37 years of age, After Revia was administered, patient had the following side effects: dizziness (What is dizziness?), feeling of body temperature change, myalgia, vomiting.

5843685-5 | Abdominal Pain, Anxiety, Chills, Myalgia, Mydriasis, Tremor
on Jul 28, 2008 Female patient from FRANCE , 24 years of age, was treated with Revia (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anxiety (What is anxiety?), chills, myalgia, mydriasis, tremor. Revia dosage: 1 Dosage Form 1 Day. During the same period patient was treated with METHADONE HCL (20 Milliliter) (View Methadone Hcl Review and Methadone Hcl Label ). Patient was hospitalized.


5827242-2 | Anorexia, Diarrhoea, Gastrointestinal Inflammation, Vomiting
on Jul 14, 2008 Male patient from SWEDEN , 58 years of age, was diagnosed with alcoholism (What is alcoholism?) and was treated with Revia (View Usage). Patient had the following side effects: anorexia, diarrhoea, gastrointestinal inflammation, vomiting. Revia dosage: Oral. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SERTRALINE (SERTRALINE HCL) (View Sertraline (sertraline Hcl) Review and Sertraline (sertraline Hcl) Label ), ATARAX (View Atarax Review and Atarax Label ), PROPAVAN (PROPIOMAZINE MALEATE) (View Propavan (propiomazine Maleate) Review and Propavan (propiomazine Maleate) Label ), ANTABUSE (View Antabuse Review and Antabuse Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ZOPICLONE (ZOPICLONE) (View Zopiclone (zopiclone) Review and Zopiclone (zopiclone) Label ). Patient was hospitalized.

5705455-8 | Agitation, Gastrointestinal Disorder, Hyperhidrosis, Mydriasis, Vomiting, Withdrawal Syndrome
Patient was taking Revia (View Usage). After Revia was administered, patient had the following side effects: agitation, gastrointestinal disorder, hyperhidrosis, mydriasis, vomiting, withdrawal syndrome on Apr 02, 2008 from FRANCE Additional patient health information: Male patient , 37 years of age, was diagnosed with alcohol abuse and. Revia dosage: 1 Dosage. During the same period patient was treated with SUBUTEX (8 Milligram 2/1 Day;) (View Subutex Review and Subutex Label ). Patient was hospitalized.

5694402-3 | Abdominal Pain, Chills, Hyperhidrosis, Myalgia, Somnolence, Yawning
Adverse event was reported on Mar 19, 2008 by a Male patient taking Revia (View Usage) (Dosage: 50 Milligram 1 Day) . Location: FRANCE , 24 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), chills, hyperhidrosis, myalgia, somnolence, yawning. During the same period patient was treated with SUBUTEX (8 Milligram 1 Day) (View Subutex Review and Subutex Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ), SEROPLEX (ESCITALOPRAM OXALATE) (View Seroplex (escitalopram Oxalate) Review and Seroplex (escitalopram Oxalate) Label ). Patient was hospitalized.

5625822-0 | Abdominal Pain Upper, Amnesia, Anxiety, Cerebrovascular Accident, Chills, Confusional State, Dehydration, Diarrhoea
on Feb 03, 2008 Male patient from CANADA , weighting 274.9 lb, was diagnosed with fatigue, pain (What is pain?) and was treated with Revia (View Usage). Patient had the following side effects: abdominal pain upper, amnesia, anxiety (What is anxiety?), cerebrovascular accident, chills, confusional state, dehydration, diarrhoea. Revia dosage: Single, Oral. During the same period patient was treated with OXYCONTIN (80 Mg, Bid, Oral) (View Oxycontin Review and Oxycontin Label ).

5566298-1 | Aphasia, Dysphagia, Pruritus, Tetanus
on Nov 20, 2007 Male patient from FRANCE , 60 years of age, was treated with Revia (View Usage). After Revia was administered, patient had the following side effects: aphasia (What is aphasia?), dysphagia, pruritus, tetanus (What is tetanus?). Revia dosage: 1 Dosage Form Oral. During the same period patient was treated with SEROPLEX (ESCITALOPRAM OXALATE) (View Seroplex (escitalopram Oxalate) Review and Seroplex (escitalopram Oxalate) Label ), ZOPICLONE (ZOPICLONE) (View Zopiclone (zopiclone) Review and Zopiclone (zopiclone) Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), HYDROXIUM (ERGOLOID MESYLATES) (View Hydroxium (ergoloid Mesylates) Review and Hydroxium (ergoloid Mesylates) Label ).

5518113-X | Agitation, Confusional State, Hypertension, Hypothermia, Hypoxia, Stress Cardiomyopathy, Supraventricular Tachycardia
Patient was taking Revia (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, confusional state, hypertension, hypothermia (What is hypothermia?), hypoxia, stress cardiomyopathy, supraventricular tachycardia on Nov 06, 2007 from FRANCE Additional patient health information: Male patient , 44 years of age, . Revia dosage: 50 Milligram Oral. During the same period patient was treated with METHADON HCL TAB (120 Milligram 1 Day Oral) (View Methadon Hcl Tab Review and Methadon Hcl Tab Label ), MIDAZOLAM HCL (10 Milligram 1 Day Iv) (View Midazolam Hcl Review and Midazolam Hcl Label ), AOTAL (ACAMPROSATE) (Oral) (View Aotal (acamprosate) Review and Aotal (acamprosate) Label ), TRANXENE (CLORAZEPATGE DIPOTASSIUM) (View Tranxene (clorazepatge Dipotassium) Review and Tranxene (clorazepatge Dipotassium) Label ). Patient was hospitalized.

5493099-5 | Abnormal Behaviour, Agitation, Disorientation, Hot Flush, Muscle Spasms, Tremor
Adverse event was reported on Oct 08, 2007 by a Male patient taking Revia (View Usage) (Dosage: 50 Milligram 1 Day) was diagnosed with sciatica (What is sciatica?) and. Location: FRANCE , 61 years of age, Patient had the following side effects: abnormal behaviour, agitation, disorientation, hot flush, muscle spasms, tremor. During the same period patient was treated with DURAGESIC 100 (75 Microgram 1/3 Day Td) (View Duragesic-100 Review and Duragesic-100 Label ), AOTAL (ACAMPROSATE) (View Aotal (acamprosate) Review and Aotal (acamprosate) Label ), VITAMIN B1 + B6 (THIAMINE + PYRIDOXINE) (View Vitamin B1 + B6 (thiamine + Pyridoxine) Review and Vitamin B1 + B6 (thiamine + Pyridoxine) Label ), NICOBION (NICOTINAMIDE) (View Nicobion (nicotinamide) Review and Nicobion (nicotinamide) Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ). Patient was hospitalized.

5485188-6 | Alcoholism, Blood Pressure Increased, Hyperhidrosis, Stress, Tachycardia
on Sep 25, 2007 Male patient from FRANCE , 23 years of age, was diagnosed with alcoholism (What is alcoholism?) and was treated with Revia (View Usage). After Revia was administered, patient had the following side effects: alcoholism (What is alcoholism?), blood pressure increased, hyperhidrosis, stress (What is stress?), tachycardia. Revia dosage: . During the same period patient was treated with SUBUTEX (8 Milligram 1/1 Day) (View Subutex Review and Subutex Label ), VALIUM (View Valium Review and Valium Label ), THIAMINE (THIAMINE) (View Thiamine (thiamine) Review and Thiamine (thiamine) Label ).

5306126-2 | Renal Failure Acute
on Apr 11, 2005 Male patient from FRANCE , 39 years of age, weighting 132.3 lb, was diagnosed with alcoholic psychosis, gallbladder disorder, urinary incontinence (What is urinary incontinence?) and was treated with Revia (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Revia dosage: . During the same period patient was treated with QUESTRAN (View Questran Review and Questran Label ), VIDEX (View Videx Review and Videx Label ), VIRAMUNE (View Viramune Review and Viramune Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), DITROPAN (View Ditropan Review and Ditropan Label ), PERIKABIVEN (View Perikabiven Review and Perikabiven Label ), ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE (View Aluminum Hydroxide And Magnesium Trisilicate Review and Aluminum Hydroxide And Magnesium Trisilicate Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

5283047-5 | Amblyopia, Headache, Neuropathy, Tunnel Vision, Visual Acuity Reduced
Patient was taking Revia (View Usage). Patient had the following side effects: amblyopia, headache (What is headache?), neuropathy, tunnel vision, visual acuity reduced on Mar 22, 2007 from FRANCE Additional patient health information: Male patient , 41 years of age, was diagnosed with alcoholism (What is alcoholism?) and. Revia dosage: 50 Milligram 1/1 Day Oral. During the same period patient was treated with EQUANIL (View Equanil Review and Equanil Label ), DISULFIRAM (View Disulfiram Review and Disulfiram Label ).

5225009-X | Thrombocytopenia
Adverse event was reported on Sep 08, 2006 by a Male patient taking Revia (View Usage) (Dosage: 50 Milligram 1 Day Oral) was diagnosed with alcoholism (What is alcoholism?) and. Location: FRANCE , 61 years of age, After Revia was administered, patient had the following side effects: thrombocytopenia. During the same period patient was treated with AOTAL (ACAMPROSATE) (View Aotal (acamprosate) Review and Aotal (acamprosate) Label ). Patient was hospitalized.

5168431-2 | Neutropenia, Thrombocytopenia
on Aug 18, 2006 Male patient from FRANCE , 32 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Revia (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, thrombocytopenia. Revia dosage: . During the same period patient was treated with MODITEN (View Moditen Review and Moditen Label ), DEPAKOTE (View Depakote Review and Depakote Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), DEROXAT (View Deroxat Review and Deroxat Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

5092960-3 | Neutropenia, Thrombocytopenia
on Aug 18, 2006 Male patient from FRANCE , 32 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Revia (View Usage). Patient had the following side effects: neutropenia, thrombocytopenia. Revia dosage: . During the same period patient was treated with MODITEN (View Moditen Review and Moditen Label ), DEPAKOTE (View Depakote Review and Depakote Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), DEROXAT (View Deroxat Review and Deroxat Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

5080728-3 | Sciatica
Patient was taking Revia (View Usage). After Revia was administered, patient had the following side effects: sciatica (What is sciatica?) on Jul 17, 2006 from AUSTRALIA Additional patient health information: Female patient , 21 years of age, was diagnosed with alcohol rehabilitation and. Revia dosage: 1 Day Oral. Patient was hospitalized.

4873342-3 | Alcohol Detoxification, Cutaneous Vasculitis, Hepatitis C Positive, Hyperkeratosis, Localised Infection, Rash Erythematous, Superinfection
Adverse event was reported on Dec 20, 2005 by a Male patient taking Revia (View Usage) (Dosage: 50 Milligram 1 Day Oral) was diagnosed with alcoholism (What is alcoholism?), hypertension, hyperkeratosis, ulcer (What is ulcer?), hypothyroidism and. Location: FRANCE , 65 years of age, Patient experienced the following unwanted or unexpected effects: alcohol detoxification, cutaneous vasculitis, hepatitis c positive, hyperkeratosis, localised infection, rash erythematous, superinfection. During the same period patient was treated with ALDACTONE (25 Milligram 1 Day) (View Aldactone Review and Aldactone Label ), OFLOXACIN (400 Milligram 1 Day) (View Ofloxacin Review and Ofloxacin Label ), LANSOPRAZOLE (30 Milligram 1 Day) (View Lansoprazole Review and Lansoprazole Label ), DILTIAZEM HCL (200 Milligram 1 Day) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), VALSARTAN (80 Milligram 1 Day) (View Valsartan Review and Valsartan Label ), LEVOTHYROXINE SODIUM (175 Microgram 1 Day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

4650096-7 | Ascites, Dehydration, Dialysis, Hyperbilirubinaemia, Renal Failure Acute, Renal Tubular Disorder
on Apr 11, 2005 Male patient from , 39 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), gallbladder disorder and was treated with Revia (View Usage). Patient had the following side effects: ascites, dehydration, dialysis (What is dialysis?), hyperbilirubinaemia, renal failure acute, renal tubular disorder. Revia dosage: 50 Milligram 1 Day Oral. During the same period patient was treated with QUESTRAN (4 Gram 3/1 Day Oral) (View Questran Review and Questran Label ), VIDEX (100 Milligram 4/1 Day Oral) (View Videx Review and Videx Label ), VIRAMUNE (200 Milligram 2/1 Day) (View Viramune Review and Viramune Label ), ZIAGEN (300 Milligram 2/1 Day) (View Ziagen Review and Ziagen Label ), PERIKABIVEN (AMINO ACID+CARBOHYDRATE+LIPID+ELECTROLYTE INFUSION) (View Perikabiven (amino Acid+carbohydrate+lipid+electrolyte Infusion) Review and Perikabiven (amino Acid+carbohydrate+lipid+electrolyte Infusion) Label ), SMECTA (SMECTITE BEIDELLITIQUE) (View Smecta (smectite Beidellitique) Review and Smecta (smectite Beidellitique) Label ), ATARAX (View Atarax Review and Atarax Label ), TRANXENE (View Tranxene Review and Tranxene Label ). Patient was hospitalized.

4641404-1 | Renal Failure Acute
on Apr 11, 2005 Male patient from , 39 years of age, weighting 132.3 lb, was diagnosed with alcoholic psychosis, gallbladder disorder, urinary incontinence (What is urinary incontinence?) and was treated with Revia (View Usage). After Revia was administered, patient had the following side effects: renal failure acute. Revia dosage: . During the same period patient was treated with QUESTRAN (View Questran Review and Questran Label ), VIDEX (View Videx Review and Videx Label ), VIRAMUNE (View Viramune Review and Viramune Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), DITROPAN (View Ditropan Review and Ditropan Label ), PERIKABIVEN (View Perikabiven Review and Perikabiven Label ), SMECTA (View Smecta Review and Smecta Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.